• 1. Estimates of hydride ion stability in condensed systems: energy of formation and solvation in aqueous and polar-organic solvents
  Craig A. Kelly,David R. Rosseinsky Phys. Chem. Chem. Phys., 2001,3, 2086-2090
• 2. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283
• 3. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 4. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 5. Emulsion soft templating of carbide-derived carbon nanospheres with controllable porosity for capacitive electrochemical energy storage?
  M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990

Market Research and Analysis of 1-(1-tert-butyl-1H-pyrazol-5-yl)ethan-1-one in the Chemical-Biomedical Field

The compound 1-(1-tert-butyl-1H-pyrazol-5-yl)ethan-1-one, identified by the CAS registry number 1508689-54-0, has garnered significant attention in the chemical-biomedical field due to its unique structural properties and potential applications in drug discovery and development. This research brief aims to provide a comprehensive analysis of the current market landscape, research advancements, and future prospects for this compound.

Recent studies have highlighted the role of 1-(1-tert-butyl-1H-pyrazol-5-yl)ethan-1-one as a promising scaffold in medicinal chemistry. Its pyrazole ring system, combined with a ketone group, offers versatile binding capabilities, making it an attractive candidate for targeting various biological pathways. The compound has been explored in preclinical models for its potential anti-inflammatory, anti-cancer, and neuroprotective activities.

Market demand for this compound is driven by its use in academic research, pharmaceutical development, and as an intermediate in chemical synthesis. Global suppliers have reported increased orders from research institutions and biotech companies seeking to leverage this compound's properties for novel drug candidates. Additionally, the growing emphasis on personalized medicine and targeted therapies has further fueled interest in compounds like 1-(1-tert-butyl-1H-pyrazol-5-yl)ethan-1-one.

To address the rising demand, manufacturers are optimizing production processes to ensure scalability and cost-effectiveness. Advanced synthetic methodologies, including microwave-assisted synthesis and catalytic techniques, are being employed to enhance the yield and purity of this compound. These efforts are expected to lower production costs and make the compound more accessible to researchers worldwide.

Looking ahead, the integration of artificial intelligence (AI) and machine learning (ML) into drug discovery pipelines is anticipated to accelerate the development of derivatives based on 1-(1-tert-butyl-1H-pyrazol-5-yl)ethan-1-one. These technologies can predict optimal structural modifications to enhance pharmacokinetic properties and minimize adverse effects.

In conclusion, 1-(1-tert-butyl-H-pyrazol--yl)ethan--one represents a valuable asset in the chemical-biomedical industry. Its diverse applications, coupled with ongoing advancements in synthesis and computational tools, position it as a key player in future therapeutic innovations. Stakeholders are advised to closely monitor emerging research trends and market dynamics to capitalize on this promising compound's potential.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)